Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Inventory (2020 - 2025)

Pulmonx (LUNG) has disclosed Inventory for 7 consecutive years, with $16.2 million as the latest value for Q2 2025.

  • On a quarterly basis, Inventory fell 4.74% to $16.2 million in Q2 2025 year-over-year; TTM through Jun 2025 was $16.2 million, a 4.74% decrease, with the full-year FY2024 number at $16.9 million, up 1.03% from a year prior.
  • Inventory was $16.2 million for Q2 2025 at Pulmonx, down from $16.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $17.2 million in Q1 2024 to a low of $14.6 million in Q4 2022.
  • A 5-year average of $16.2 million and a median of $16.3 million in 2021 define the central range for Inventory.
  • Peak YoY movement for Inventory: soared 51.62% in 2021, then decreased 10.57% in 2022.
  • Pulmonx's Inventory stood at $16.3 million in 2021, then dropped by 10.57% to $14.6 million in 2022, then grew by 14.96% to $16.7 million in 2023, then rose by 1.03% to $16.9 million in 2024, then decreased by 4.37% to $16.2 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Inventory are $16.2 million (Q2 2025), $16.8 million (Q1 2025), and $16.9 million (Q4 2024).